Paul J. Hastings, Director at Pacira Pharmaceuticals, Inc. (PCRX), sold 771 shares at $33.90 ($26K) on 2018-06-04, disclosed to the SEC on 2018-06-06.
Seasonal sale ($26k) by Director — this insider has traded PCRX in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| NKTX | SELL | 2025-06-20 | $3K | — | Filing → |
| NKTX | SELL | 2025-01-17 | $38K | — | Filing → |
| NKTX | SELL | 2024-06-20 | $10K | — | Filing → |